Kezar Life Sciences, Inc. — Director's Dealing 2018

Jun 20, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-20

Reporting Person: Sommadossi Jean-Pierre (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	90601	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$5.91	2028-04-15	Common Stock (8896)		Direct
Series A Convertible Perferred Stock	$		Common Stock (52581)		Indirect
Series B Convertible Perferred Stock	$		Common Stock (35258)		Indirect

Footnotes

F1: One-hundred percent (100%) of the shares subject to the option shall vest on January 1, 2019, subject to Reporting Person continuing to provide service through such date.

F2: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.